Nautilus Biotechnolgy
NAUT
43 hedge funds and large institutions have $143M invested in Nautilus Biotechnolgy in 2020 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 10 reducing their positions, and 7 closing their positions.
14% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 7
5% more capital invested
Capital invested by funds: $136M → $143M (+$7.15M)
3.74% more ownership
Funds ownership: 81.81% → 85.54% (+3.7%)
2% more funds holding
Funds holding: 42 → 43 (+1)
40% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$5.27M |
| 2 |
CCM
Context Capital Management
Lajolla,
California
|
+$2.75M |
| 3 |
Goldman Sachs
New York
|
+$1.29M |
| 4 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
+$1.28M |
| 5 |
DKCM
Davidson Kempner Capital Management
New York
|
+$691K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Boxer Capital
San Diego,
California
|
-$6.27M |
| 2 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$2.11M |
| 3 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$1.62M |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$1.07M |
| 5 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
-$729K |
NAUT Hedge Fund Activity: Q4 2020 in Review
43 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in Nautilus Biotechnolgy (NAUT) for Q4 2020, worth a combined $143M — up 5.2% from $136M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new NAUT positions and 7 closed out — a net gain of 1 holder — while 6 added to existing stakes and 10 trimmed.
The largest buyer was Avidity Partners Management, opening a new position worth an estimated $5.27M. The largest seller was Boxer Capital, exiting entirely with an estimated $6.27M sold.
- 43 institutional investors held Nautilus Biotechnolgy (NAUT) as of Q4 2020, up from 42 in Q3 2020.
- Funds reported $143M of Nautilus Biotechnolgy stock for Q4 2020, up 5.2% quarter-over-quarter.
- 8 funds opened new Nautilus Biotechnolgy positions in Q4 2020 and 7 closed out, a net change of +1 holder.
- The largest Nautilus Biotechnolgy buyer in Q4 2020 was Avidity Partners Management, an estimated $5.27M added.
- The largest Nautilus Biotechnolgy seller in Q4 2020 was Boxer Capital, an estimated $6.27M sold.
Based on aggregated 13F filings for Q4 2020.